Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
grade F 16.32 -0.85% -0.14
KNSA closed down 0.85 percent on Monday, April 22, 2019, on 40 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical KNSA trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -0.85%
Oversold Stochastic Weakness -0.85%
Down 3 Days in a Row Weakness 0.74%
Oversold Stochastic Weakness 0.74%
MACD Bearish Centerline Cross Bearish -1.98%
Stochastic Reached Oversold Weakness -1.98%
Inside Day Range Contraction -1.98%
Oversold Stochastic Weakness -1.98%

Older signals for KNSA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:
Profile
  • Earnings date: 2019-03-07
  • Sector: Other
  • Industry: Other
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Biotechnology Health Biopharmaceutical Pharmaceutical Industry Diseases Medication Pharmaceutical Industry In China Pharmacology
Is KNSA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Apr 17 Kiniksa to Present Clinical and Preclinical Data for KPL-716 at the 77th Annual Meeting of the Society for Investigative Dermatology
Apr 8 Kiniksa to Present KPL-404 Preclinical Data at the Keystone Symposia on Antibodies as Drugs
Apr 8 SCYNEXIS and Avadel Pharmaceuticals among healthcare gainers; Midatech Pharma leads the losers
Apr 8 54 Biggest Movers From Friday
Mar 18 Kiniksa Pharmaceuticals (KNSA) Presents At American College of Cardiology's 68thAnnual Scientific Session - Slideshow
Mar 18 Kiniksa Presents Rilonacept Interim Phase 2 Clinical Data Poster at the American College of Cardiology’s 68th Annual Scientific Session
Mar 7 Kiniksa Pharmaceuticals reports Q4 results
Mar 7 Kiniksa Reports Fourth Quarter and Full-Year 2018 Financial Results and Highlights Recent Corporate and Pipeline Activity
Feb 28 Kiniksa Pharmaceuticals to Present at the Cowen and Company 39th Annual Healthcare Conference
Feb 26 Kiniksa Pharmaceuticals to Present at the Barclays Global Healthcare Conference
See more KNSA news...
Indicators
Indicator Value
52 Week High 32.88
52 Week Low 13.04
Average Volume 114,548
200-Day Moving Average 19.7511
50-Day Moving Average 17.5278
20-Day Moving Average 17.574
10-Day Moving Average 17.419
Average True Range 1.0936
ADX 16.2
+DI 18.8237
-DI 21.0668
Chandelier Exit (Long, 3 ATRs ) 18.2192
Chandelier Exit (Short, 3 ATRs ) 18.9108
Upper Bollinger Band 19.5691
Lower Bollinger Band 15.5789
Percent B (%b) 0.19
BandWidth 22.705133
MACD Line -0.2975
MACD Signal Line -0.0871
MACD Histogram -0.2104
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.40
Resistance 3 (R3) 17.42 17.09 17.22
Resistance 2 (R2) 17.09 16.81 17.08 17.16
Resistance 1 (R1) 16.70 16.64 16.54 16.68 17.10
Pivot Point 16.37 16.37 16.28 16.36 16.37
Support 1 (S1) 15.98 16.09 15.82 15.96 15.54
Support 2 (S2) 15.65 15.92 15.64 15.48
Support 3 (S3) 15.26 15.65 15.42
Support 4 (S4) 15.24